Synthesis and selective anticancer activity of steroidal glycoconjugates

European Journal of Medicinal Chemistry

Volumn 54, Issue , 2012, Pages 721-727

  Fernández Herrera, María A ^a   López Muñoz, Hugo ^b   Hernández Vázquez, José M V ^b   Sánchez Sánchez, Luis ^b   Escobar Sánchez, María L ^c   Pinto, B Mario ^a   Sandoval Ramírez, Jesús ^d  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

d Glucosamine steroidal derivatives; Antiproliferative activity; Cervicouterine cancer cells; Cytotoxicity; Diosgenin; Hecogenin; Selective antitumor activity

Indexed keywords

3,4,6 TRI O ACETYL 2 DEOXY 2 PHTHALIMIDO ALPHA,BETA,DEXTRO GLUCOPYRANOSYL TRICHLOROACETIMIDATE; ANTINEOPLASTIC AGENT; CHLORIDE; DIOSGENIN; DIOSGENIN 2 ACETAMIDO 2 DEOXY BETA DEXTRO GLUCOPYRANOSIDE; DIOSGENIN 3,4,6 TRI O ACETYL 2 DEOXY 2 PHTHALIMIDO BETA DEXTRO GLUCOPYRANOSIDE; DIOSGENYL 2 AMINO 2 DEOXY BETA DEXTRO GLUCOPYRANOSIDE; GLUCOSAMINE; GLYCOCONJUGATE; HECOGENIN; HECOGENIN 2 ACETAMIDO 2 DEOXY BETA DEXTRO GLUCOPYRANOSIDE; HECOGENIN 3,4,6 TRI O ACETYL 2 DEOXY 2 PHTHALIMIDO BETA DEXTRO GLUCOPYRANOSIDE; TRICHLOROACETIMIDIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DEATH; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; SYNTHESIS; TUMOR CELL; UTERINE CERVIX CARCINOMA;

ACETYLGLUCOSAMINE; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY TECHNIQUES, SYNTHETIC; DIOSGENIN; GLYCOSIDES; HUMANS; SAPOGENINS;

EID: 84864416231     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.06.027     Document Type: Article

References (37)

1. K. Hostettmann, and A. Marston Saponins: Chemistry and Pharmacology of Natural Products 1995 Cambridge University Press London
2. G.R. Waller, and K. Yamasaki Saponins Used in Food and Agriculture 1996 Plenum Press New York
3. G.R. Waller, and K. Yamasaki Saponins Used in Traditional and Modern Medicine 1996 Plenum Press New York
4. G. Francis, Z. Kerem, H.P.S. Makkar, and K. Becker The biological action of saponins in animal systems: a review Br. J. Nutr. 88 2002 587 605 (Pubitemid 36082888)
5. H. Pellissier The glycosylation of steroids Tetrahedron 60 2004 5123 5162 (Pubitemid 38680580)
6. D.B. Salunke, B.G. Hazra, and V.S. Pore Steroidal conjugates and their pharmacological applications Curr. Med. Chem. 13 2006 813 847
7. M. Thakur, M.F. Melzig, H. Fuchs, and A. Weng Chemistry and pharmacology of saponins: special focus on cytotoxic properties Botanics: Targets Ther. 1 2011 19 29
8. N. Nakashima, I. Kimura, M. Kimura, and H. Matsuura Isolation of pseudoprototimosaponin AIII from rhizomes of Anemarrhena asphodeloides and its hypoglycemic activity in steptozotocin-induced diabetic mice J. Nat. Prod. 56 1993 345 350 (Pubitemid 23104346)
9. J. Cai, M. Liu, Z. Wang, and Y. Ju Apoptosis induced by dioscin in HeLa cells Biol. Pharm. Bull. 25 2002 193 196 (Pubitemid 39592103)
10. L.A. Tapondjou, K.B. Ponou, R.B. Teponno, M. Mbiantcha, J.D. Djoukeng, T.B. Nguelefack, P. Watcho, A. Gomez-Cadenas, and H.J. Park In vivo anti-inflammatory effect of new steroidal saponin, mannioside A, and its derivatives isolated from Dracaena mannii Arch. Pharm. Res. 31 2008 653 658
11. T. Tschamber, S. Adam, Y. Matsuya, S. Masuda, N. Ohsawa, S. Maruyama, K. Kamoshita, H. Nemoto, and J. Eustache OSW-1 analogues: modification of the carbohydrate moiety Bioorg. Med. Chem. Lett. 17 2007 5101 5106 (Pubitemid 47271898)
12. P. Tang, F. Mamdani, X. Hu, J.O. Liu, and B. Yu Synthesis of OSW saponin analogs with modified sugar residues and their antiproliferative activities Bioorg. Med. Chem. Lett. 17 2007 1003 1007 (Pubitemid 46178544)
13. M.A. Fernández-Herrera, J. Sandoval-Ramírez, H. López-Muñoz, and L. Sánchez-Sánchez Formation of the steroidal 3β-hydroxy-6-oxo-moiety. Synthesis and cytotoxicity of glucolaxogenin Arkivoc xiii 2009 170 184
14. M.A. Lacaille-Dubois Bioactive saponins with cancer related and immunomodulatory activity: recent developments Atta-Ur-Rahman Studies in Natural Products Chemistry Series vol. 32 2005 Elsevier Sciences Amsterdam pp. 209-246
15. D. Acharya, A.C. Mitaine-Offer, N. Kaushik, T. Miyamoto, T. Paululat, J.F. Mirjolet, O. Duchamp, and M.A. Lacaille-Dubois Steroidal saponins from Chlorophytum orchidastrum J. Nat. Prod. 73 2010 7 11
16. J. Banoub, P. Boullanger, and D. Lafont Synthesis of oligosaccharides of 2-amino-2-deoxy sugars Chem. Rev. 92 1992 1167 1195
17. O.T. Leung, S.P. Douglas, D.M. Whitfield, H.Y.S. Pang, and J.J. Krepinsky Syntheses of model oligosaccharides of biological significance. XIII. Syntheses of derivatives of GalpNAc(β1-4)Galp(β1-O), the common binding theme of adhesins of various bacteria: solution and polymer-supported solution approaches. An improved preparation of 2-deoxy-2-phthalimido-1,3,4,6-tetra-O- acetyl galactosamine and glucosamine New J. Chem. 18 1994 349 363
18. M.A. Fernández-Herrera, H. López-Muñoz, J.M.V. Hernández-Vázquez, M. López-Dávila, M.L. Escobar-Sánchez, L. Sánchez-Sánchez, B.M. Pinto, and J. Sandoval-Ramírez Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells Bioorg. Med. Chem. 18 2010 2474 2484
19. M.A. Fernández-Herrera, S. Mohan, H. López-Muñoz, J.M.V. Hernández-Vázquez, E. Pérez-Cervantes, M.L. Escobar-Sánchez, L. Sánchez-Sánchez, I. Regla, B.M. Pinto, and J. Sandoval-Ramírez Synthesis of the steroidal glycoside (25R)-3β,16β-diacetoxy-12,22-dioxo-5α-cholestan-26-yl β-D-glucopyranoside and its anticancer properties on cervicouterine HeLa, CaSki, and ViBo cells Eur. J. Med. Chem. 45 2010 4827 4837
20. M.A. Fernández-Herrera, H. López-Muñoz, J.M.V. Hernández-Vázquez, M. López-Dávila, S. Mohan, M.L. Escobar-Sánchez, L. Sánchez-Sánchez, B.M. Pinto, and J. Sandoval-Ramírez Synthesis and biological evaluation of the glycoside (25R)-3β,16β-diacetoxy-22-oxocholest-5-en-26-yl β-D- glucopyranoside: a selective anticancer agent in cervicouterine cell lines Eur. J. Med. Chem. 46 2011 3877 3886
21. R.U. Lemieux, T. Takeda, and B.Y. Chung Synthesis of 2-amino-2-deoxy- β-D-glucopyranosides ACS Symp. Ser. 39 1976 90 115
22. J.R. Marino-Albernas, S.L. Harris, V. Varma, and B.M. Pinto Convergent synthesis of an elusive hexasaccharide corresponding to the cell-wall polysaccharide of the β-hemolytic Streptococcus group A Carbohydr. Res. 245 1993 245 257 (Pubitemid 23213333)
23. F.I. Auzanneau, F. Forooghian, and B.M. Pinto Efficient, convergent synthesis of oligosaccharide allyl glycosides corresponding to the Streptococcus group A cell-wall polysaccharide Carbohydr. Res. 291 1996 21 41 (Pubitemid 26300445)
24. B.D. Johnston, and B.M. Pinto Synthesis of heteroanalogues of disaccharides as potential inhibitors of the processing mannosidase class I enzymes Carbohydr. Res. 310 1998 17 25 (Pubitemid 28446183)
25. C. Höög, A. Rotondo, B.D. Johnston, and B.M. Pinto Synthesis and conformational analysis of a pentasaccharide corresponding to the cell-wall polysaccharide of the group A Steptococcus Carbohydr. Res. 337 2002 2023 2036 (Pubitemid 35335852)
26. W. Kueng, E. Silber, and U. Eppenberger Quantification of cells cultured on 96-well plates Anal. Biochem. 182 1989 16 19 (Pubitemid 19251274)
27. C. Legrand, J.M. Bour, C. Jacob, J. Capiaumont, A. Martial, A. Marc, M. Wudtke, G. Kretzmer, C. Demangel, D. Duval, and J. Hache Lactate dehydrogenase (LDH) activity of the number of dead cells in the medium of cultured eukaryotic cells as marker J. Biotechnol. 25 1992 231 243
28. H.M. Shapiro Practical Flow Cytometry second ed. 1988 Alan R. Liss, Inc New York
29. L.H. Hartwell, and T.A. Weinert Checkpoints: controls that ensure the order of cell cycle events Science 246 1989 629 634 (Pubitemid 19283354)
30. Z. Darzynkiewicz Nucleic acid analysis J.P. Robinson, Current Protocols in Cytometry 1997 John Wiley & Sons, Inc New York (Chapter 7)
31. 1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol Cancer Res. 59 1999 4634 4641 (Pubitemid 29428969)
32. C.J. Sherr The Pezcoller lecture: cancer cell cycles revisited Cancer Res. 60 2000 3689 3695 (Pubitemid 32204552)
33. A.M. Senderowicz, and E.A. Sausville Preclinical and clinical development of cyclin-dependent kinase modulators J. Natl. Cancer Inst. 92 2000 376 387 (Pubitemid 30154819)
34. J.R. Jackson, A. Gilmartin, C. Imburgia, J.D. Winkler, L.A. Marshall, and A. Roshak An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage Cancer Res. 60 2000 566 572 (Pubitemid 30094552)
35. 2 checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells Cancer Res. 61 2001 5843 5849 (Pubitemid 32769103)
36. F. McLaughlin, P. Finn, and N.B. La Thangue The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age Drug Discov. Today 8 2003 793 802 (Pubitemid 37011305)
37. A.B. Lyons, J. Hasbold, and P.D. Hodgkin Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe Methods Cell Biol. 63 2001 375 398